2019 ASM/ESCMID Conference on Drug Development

3 September 2019
Boston, USA

Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR.

The 6th Nikkei Asia Africa Conference on Communicable Diseases 2019

31 August 2019
Kanagawa, Japan

Nikkei Inc. has been organizing the annual Nikkei Asian Conference on Communicable Diseases since 2014, gathering internationally renowned experts in the field, both within and outside Japan, representatives of the private sector, and high-ranking government officials responsible for health.

ASM Microbe 2019

20 June 2019
San Francisco, USA

Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session, drug discovery efforts originating from academic laboratories will be discussed.

Time for concrete action – Addressing the global AMR crisis

21 May 2019
Geneva, Switzerland

An unmissable opportunity to hear from international AMR experts delving into one of today’s biggest health threats and to unite in advancing solutions for this pressing global concern. The talks and panel discussion will be followed by a reception.

Webinar on mining chemical libraries for new antibacterials

9 April 2019
Time: 17:00-18:30 CET

In this webinar, Carl Balibar (Merck Research Laboratories) will discuss screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.

Webinar on the various mechanisms of support offered by NIAID to facilitate discovery and development of anti-infectives

21 February 2019
Time: 17:00-18:30 CET

In this presentation, Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID) provided an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs, vaccines, and diagnostics targeting infectious diseases. Dan Pevear, Senior Vice President, Biology and Grants Development, VenatoRx Pharmaceuticals, shared VenatoRx’ experience with NIAID support mechanisms.

Watch the webinar

Antimicrobial Chemotherapy Conference 2019

15 January 2019
London, UK

Laura Piddock, Head of Scientific Affairs, and Astrid Pentz-Murr, Community manager REVIVE – session on tackling beta-lactamase mediated resistance
Emilie Alirol, Project Leader, Sexually Transmitted Infections – presentation on the development of a new drug for STIs